
|Articles|November 15, 2003
AMO sharpens focus on innovative technology
Author(s)Mark L. Dlugoss
A sign of an excellent company is one that capitalizes on its strengths, minimizes its weaknesses, takes advantage of its opportunities, and recognizes its threats, according to James V. Mazzo, president and chief executive officer of Advanced Medical Optics (AMO).
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
NeuroOp Guru: When proptosis isn’t thyroid eye disease
2
FDA clears BVI’s FineVision HP trifocal IOL for the US market
3
FDA approves Rayner’s RayOne EMV Toric intraocular lens
4
Ophthalmic innovation by the decades: The 1980s and 1990s
5